HILE(SH:603718) Xin Lang Cai Jing·2026-01-16 01:49Group 1 - The core viewpoint of the news is that Haili Biological experienced a decline in stock price and trading volume, with significant details on financing and stockholder changes [1][2] Group 2 - On January 15, Haili Biological's stock fell by 1.83%, with a trading volume of 83.6 million yuan [1] - The financing data shows that on the same day, Haili Biological had a financing purchase amount of 9.52 million yuan, with a net financing purchase of 2.78 million yuan [1] - As of January 15, the total balance of margin trading for Haili Biological was 212 million yuan, with the financing balance accounting for 5.06% of the circulating market value, indicating a low level compared to the past year [1] - In terms of securities lending, Haili Biological had a securities lending repayment of 1,300 shares and a securities lending sell of 2,000 shares, with a total lending balance of 44.05 million yuan, also at a low level compared to the past year [1] Group 3 - As of September 30, the number of shareholders for Haili Biological increased to 33,800, a rise of 7.16%, while the average circulating shares per person decreased by 6.68% [2] - For the period from January to September 2025, Haili Biological reported a revenue of 150 million yuan, a year-on-year decrease of 14.15%, while the net profit attributable to the parent company was 20.33 million yuan, reflecting a slight increase of 0.77% [2] - Haili Biological has distributed a total of 209 million yuan in dividends since its A-share listing, with 107 million yuan distributed over the past three years [2] - Among the top ten circulating shareholders as of September 30, 2025, Guotai Zhongzheng Livestock Breeding ETF ranked as the fifth largest shareholder, increasing its holdings by 3.70 million shares to 10.23 million shares [2]